Log in to save to my catalogue

The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermi...

The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2630412866

The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions

About this item

Full title

The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions

Publisher

Switzerland: Frontiers Research Foundation

Journal title

Frontiers in neuroscience, 2022-02, Vol.16, p.806990-806990

Language

English

Formats

Publication information

Publisher

Switzerland: Frontiers Research Foundation

More information

Scope and Contents

Contents

Synaptic gene conditions, i.e., “synaptopathies,” involve disruption to genes expressed at the synapse and account for between 0.5 and 2% of autism cases. They provide a unique entry point to understanding the molecular and biological mechanisms underpinning autism-related phenotypes. Phelan-McDermid Syndrome (PMS, also known as 22q13 deletion synd...

Alternative Titles

Full title

The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2630412866

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2630412866

Other Identifiers

ISSN

1662-453X,1662-4548

E-ISSN

1662-453X

DOI

10.3389/fnins.2022.806990

How to access this item